Galvin Roy
Galvin Roy, EVP, CCO, reported a transaction classified as withholding at HAEMONETICS CORP involving 146.000000 shares for an estimated $17468.90. Reported holdings after the transaction were 39805.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 30, 2026
- Filing date
- Nov 03, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
HAE price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0000313143-26-000144 Common Stock
- Transaction date
- Oct 30, 2026 Filed Nov 03, 2026, 09:15 PM · 4d delay
- Shares
- 146 sh $119.65 per share
- Estimated value
- -$17.4k Computed from shares × price
- Holdings after
- 39,805 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP, Chief Commercial Officer
- F1
Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
- F2
This number includes unvested RSUs previously reported as well as 69 shares acquired by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or rest…
0 other transactions
0 recent txs